These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 36758422)

  • 1. Financial toxicity: A practical review for gynecologic oncology teams to understand and address patient-level financial burdens.
    Liang MI; Harrison R; Aviki EM; Esselen KM; Nitecki R; Meyer L
    Gynecol Oncol; 2023 Mar; 170():317-327. PubMed ID: 36758422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extensive financial hardship among gynecologic cancer patients starting a new line of therapy.
    Liang MI; Pisu M; Summerlin SS; Boitano TKL; Blanchard CT; Bhatia S; Huh WK
    Gynecol Oncol; 2020 Feb; 156(2):271-277. PubMed ID: 31771866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Greater financial toxicity relates to greater distress and worse quality of life among breast and gynecologic cancer survivors.
    Benedict C; Fisher S; Schapira L; Chao S; Sackeyfio S; Sullivan T; Pollom E; Berek JS; Kurian AW; Palesh O
    Psychooncology; 2022 Jan; 31(1):9-20. PubMed ID: 34224603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Financial toxicity in gynecologic oncology.
    Bouberhan S; Shea M; Kennedy A; Erlinger A; Stack-Dunnbier H; Buss MK; Moss L; Nolan K; Awtrey C; Dalrymple JL; Garrett L; Liu FW; Hacker MR; Esselen KM
    Gynecol Oncol; 2019 Jul; 154(1):8-12. PubMed ID: 31053404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-reported benefit from proposed interventions to reduce financial toxicity during cancer treatment.
    Aviki EM; Thom B; Braxton K; Chi AJ; Manning-Geist B; Chino F; Brown CL; Abu-Rustum NR; Gany FM
    Support Care Cancer; 2022 Mar; 30(3):2713-2721. PubMed ID: 34822002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating meaningful levels of financial toxicity in gynecologic cancers.
    Esselen KM; Gompers A; Hacker MR; Bouberhan S; Shea M; Summerlin SS; Rucker LR; Huh WK; Pisu M; Liang MI
    Int J Gynecol Cancer; 2021 Jun; 31(6):801-806. PubMed ID: 33858954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Financial toxicity in patients with gynecologic malignancies: a cross sectional study.
    Zeybek B; Webster E; Pogosian N; Tymon-Rosario J; Balch A; Altwerger G; Clark M; Menderes G; Huang G; Azodi M; Ratner ES; Schwartz PE; Santin AD; Andikyan V
    J Gynecol Oncol; 2021 Nov; 32(6):e87. PubMed ID: 34431257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for financial toxicity in patients with gynecologic cancer.
    Aviki EM; Manning-Geist BL; Sokolowski SS; Newman T; Blinder VS; Chino F; Doyle SM; Liebhaber A; Gordhandas SB; Brown CL; Broach V; Chi DS; Jewell EL; Leitao MM; Long Roche K; Mueller JJ; Sonoda Y; Zivanovic O; Gardner GJ; Abu-Rustum NR
    Am J Obstet Gynecol; 2022 Jun; 226(6):817.e1-817.e9. PubMed ID: 34902319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crowdsourcing to measure financial toxicity in gynecologic oncology.
    Esselen KM; Stack-Dunnbier H; Gompers A; Hacker MR
    Gynecol Oncol; 2021 May; 161(2):595-600. PubMed ID: 33551197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with increased financial toxicity after the completion of radiation treatment for gynecologic cancer.
    Esselen KM; Baig RA; Gompers A; Stack-Dunnbier H; Hacker MR; Jang JW
    Support Care Cancer; 2023 Jun; 31(7):388. PubMed ID: 37300721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Financial toxicity in cancer care: origins, impact, and solutions.
    Abrams HR; Durbin S; Huang CX; Johnson SF; Nayak RK; Zahner GJ; Peppercorn J
    Transl Behav Med; 2021 Nov; 11(11):2043-2054. PubMed ID: 34850932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Financial toxicity, mental health, and gynecologic cancer treatment: The effect of the COVID-19 pandemic among low-income women in New York City.
    Chen YS; Zhou ZN; Glynn SM; Frey MK; Balogun OD; Kanis M; Holcomb K; Gorelick C; Thomas C; Christos PJ; Chapman-Davis E
    Cancer; 2021 Jul; 127(14):2399-2408. PubMed ID: 33899220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between financial toxicity and health-related quality of life of patients with gynecologic cancer.
    Kajimoto Y; Honda K; Suzuki S; Mori M; Tsubouchi H; Nakao K; Azuma A; Shibutani T; Nagao S; Koyanagi T; Kohara I; Tamaki S; Yabuki M; Teng L; Fujiwara K; Igarashi A
    Int J Clin Oncol; 2023 Mar; 28(3):454-467. PubMed ID: 36648710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Financial toxicity, coping strategies, and quality of life among Chinese patients with hematologic malignancies: a cross-sectional study.
    Wang Y; Luo B; Wang X; Ji Q; Cao X
    Support Care Cancer; 2024 Jul; 32(7):475. PubMed ID: 38954081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Conceptual Model of Financial Toxicity in Pediatric Oncology.
    Santacroce SJ; Kneipp SM
    J Pediatr Oncol Nurs; 2019; 36(1):6-16. PubMed ID: 30798687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The patient-level effect of the cost of Cancer care - financial burden in German Cancer patients.
    Mehlis K; Witte J; Surmann B; Kudlich M; Apostolidis L; Walther J; Jäger D; Greiner W; Winkler EC
    BMC Cancer; 2020 Jun; 20(1):529. PubMed ID: 32503459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic distress, financial toxicity, and medical cost-coping in young adult cancer survivors during the COVID-19 pandemic: Findings from an online sample.
    Thom B; Benedict C; Friedman DN; Watson SE; Zeitler MS; Chino F
    Cancer; 2021 Dec; 127(23):4481-4491. PubMed ID: 34351638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Financial Burdens of Cancer Treatment: A Systematic Review of Risk Factors and Outcomes.
    Smith GL; Lopez-Olivo MA; Advani PG; Ning MS; Geng Y; Giordano SH; Volk RJ
    J Natl Compr Canc Netw; 2019 Oct; 17(10):1184-1192. PubMed ID: 31590147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of two validated instruments to measure financial hardship in cancer survivors: comprehensive score for financial toxicity (COST) versus personal financial wellness (PFW) scale.
    D'Rummo KA; Nganga D; Chollet-Hinton L; Shen X
    Support Care Cancer; 2022 Dec; 31(1):12. PubMed ID: 36513902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lessening the Impact of Financial Toxicity (LIFT): a protocol for a multi-site, single-arm trial examining the effect of financial navigation on financial toxicity in adult patients with cancer in rural and non-rural settings.
    Wheeler SB; Biddell CB; Manning ML; Gellin MS; Padilla NR; Spees LP; Rogers CD; Rodriguez-O'Donnell J; Samuel-Ryals C; Birken SA; Reeder-Hayes KE; Petermann VM; Deal AM; Rosenstein DL
    Trials; 2022 Oct; 23(1):839. PubMed ID: 36192802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.